NCT03989557View on ClinicalTrials.gov

Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial Aneurysms

PHASE4CompletedINTERVENTIONAL
Enrollment

314

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

July 20, 2020

Study Completion Date

August 13, 2020

Conditions
Unruptured Intracranial AneurysmStentsAntiplatelet Drugs
Interventions
DRUG

Aspirin and clopidogrel/Ticagrelor

The modification of aspirin and clopidogrel/ticagrelor maintenance doses based on a biomarker assays.

DEVICE

Light transmittance aggregometry

point-of-care method to assess platelet function by light transmittance aggregometry.

DRUG

Aspirin and clopidogrel/Ticagrelor

maintenance dose of aspirin, clopidogrel and ticagrelor.

Trial Locations (1)

100050

Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Beijing

All Listed Sponsors
lead

Beijing Neurosurgical Institute

OTHER

NCT03989557 - Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial Aneurysms | Biotech Hunter | Biotech Hunter